Clinical Trial Update: Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating how race/ethnicity and other factors influence response to abiraterone acetate plus prednisone in metastatic hormone-naive prostate can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hormone-naive Prostate Cancer

Drugs mentioned

• PREDNISONE (Prednisone)
• Zytiga (abiraterone acetate)

Snippet

Sponsor: Martha Mims | Conditions: Prostate Cancer Metastatic, Prostate Cancer | Phase 2 | Status: RECRUITING